JOSEPH SIRAGUSA: Open Payments
NPI 1376957761 · WOODCLIFF LAKE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 34 payments from 9 companies in 2025. Trend: 2023 $70 · 2024 $136 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $225 |
| Alkermes, Inc. | 7 | $126 |
| ABBVIE INC. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Tris Pharma Inc | 2 | $35 |
| Corium, LLC | 3 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: INGREZZA, VRAYLAR, ARISTADA, REXULTI, LYBALVI, UZEDY, COBENFY, Dyanavel XR.
Industry payments across NJ — which companies pay providers there.
